Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis

Objective Lupus nephritis (LN) is an immune complex-mediated glomerular and tubulointerstitial disease in patients with SLE. Prediction of outcomes at the onset of LN diagnosis can guide decisions regarding intensity of monitoring and therapy for treatment success. Currently, no machine learning mod...

Full description

Saved in:
Bibliographic Details
Main Authors: Jim C Oates, Bethany Wolf, Lindsay N Helget, David J Dillon, Laura P Parks, Sally E Self, Evelyn T Bruner, Evan E Oates
Format: Article
Language:English
Published: BMJ Publishing Group 2021-04-01
Series:Lupus Science and Medicine
Online Access:https://lupus.bmj.com/content/8/1/e000489.full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1846119809804140544
author Jim C Oates
Bethany Wolf
Lindsay N Helget
David J Dillon
Laura P Parks
Sally E Self
Evelyn T Bruner
Evan E Oates
author_facet Jim C Oates
Bethany Wolf
Lindsay N Helget
David J Dillon
Laura P Parks
Sally E Self
Evelyn T Bruner
Evan E Oates
author_sort Jim C Oates
collection DOAJ
description Objective Lupus nephritis (LN) is an immune complex-mediated glomerular and tubulointerstitial disease in patients with SLE. Prediction of outcomes at the onset of LN diagnosis can guide decisions regarding intensity of monitoring and therapy for treatment success. Currently, no machine learning model of outcomes exists. Several outcomes modelling works have used univariate or linear modelling but were limited by the disease heterogeneity. We hypothesised that a combination of renal pathology results and routine clinical laboratory data could be used to develop and to cross-validate a clinically meaningful machine learning early decision support tool that predicts LN outcomes at approximately 1 year.Methods To address this hypothesis, patients with LN from a prospective longitudinal registry at the Medical University of South Carolina enrolled between 2003 and 2017 were identified if they had renal biopsies with International Society of Nephrology/Renal Pathology Society pathological classification. Clinical laboratory values at the time of diagnosis and outcome variables at approximately 1 year were recorded. Machine learning models were developed and cross-validated to predict suboptimal response.Results Five machine learning models predicted suboptimal response status in 10 times cross-validation with receiver operating characteristics area under the curve values >0.78. The most predictive variables were interstitial inflammation, interstitial fibrosis, activity score and chronicity score from renal pathology and urine protein-to-creatinine ratio, white blood cell count and haemoglobin from the clinical laboratories. A web-based tool was created for clinicians to enter these baseline clinical laboratory and histopathology variables to produce a probability score of suboptimal response.Conclusion Given the heterogeneity of disease presentation in LN, it is important that risk prediction models incorporate several data elements. This report provides for the first time a clinical proof-of-concept tool that uses the five most predictive models and simplifies understanding of them through a web-based application.
format Article
id doaj-art-fc1250e18b6d45619532089e4b71e6ac
institution Kabale University
issn 2053-8790
language English
publishDate 2021-04-01
publisher BMJ Publishing Group
record_format Article
series Lupus Science and Medicine
spelling doaj-art-fc1250e18b6d45619532089e4b71e6ac2024-12-16T18:45:11ZengBMJ Publishing GroupLupus Science and Medicine2053-87902021-04-018110.1136/lupus-2021-000489Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosisJim C Oates0Bethany Wolf1Lindsay N Helget2David J Dillon3Laura P Parks4Sally E Self5Evelyn T Bruner6Evan E Oates7Medical Service, Ralph H Johnson VA Medical Center, Charleston, South Carolina, USAPublic Health Sciences, Medical University of South Carolina, Charleston, South Carolina, USADepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USADepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USADepartment of Medicine, Medical University of South Carolina, Charleston, South Carolina, USADepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USADepartment of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston, South Carolina, USAVanderbilt University, Nashville, Tennessee, USAObjective Lupus nephritis (LN) is an immune complex-mediated glomerular and tubulointerstitial disease in patients with SLE. Prediction of outcomes at the onset of LN diagnosis can guide decisions regarding intensity of monitoring and therapy for treatment success. Currently, no machine learning model of outcomes exists. Several outcomes modelling works have used univariate or linear modelling but were limited by the disease heterogeneity. We hypothesised that a combination of renal pathology results and routine clinical laboratory data could be used to develop and to cross-validate a clinically meaningful machine learning early decision support tool that predicts LN outcomes at approximately 1 year.Methods To address this hypothesis, patients with LN from a prospective longitudinal registry at the Medical University of South Carolina enrolled between 2003 and 2017 were identified if they had renal biopsies with International Society of Nephrology/Renal Pathology Society pathological classification. Clinical laboratory values at the time of diagnosis and outcome variables at approximately 1 year were recorded. Machine learning models were developed and cross-validated to predict suboptimal response.Results Five machine learning models predicted suboptimal response status in 10 times cross-validation with receiver operating characteristics area under the curve values >0.78. The most predictive variables were interstitial inflammation, interstitial fibrosis, activity score and chronicity score from renal pathology and urine protein-to-creatinine ratio, white blood cell count and haemoglobin from the clinical laboratories. A web-based tool was created for clinicians to enter these baseline clinical laboratory and histopathology variables to produce a probability score of suboptimal response.Conclusion Given the heterogeneity of disease presentation in LN, it is important that risk prediction models incorporate several data elements. This report provides for the first time a clinical proof-of-concept tool that uses the five most predictive models and simplifies understanding of them through a web-based application.https://lupus.bmj.com/content/8/1/e000489.full
spellingShingle Jim C Oates
Bethany Wolf
Lindsay N Helget
David J Dillon
Laura P Parks
Sally E Self
Evelyn T Bruner
Evan E Oates
Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
Lupus Science and Medicine
title Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
title_full Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
title_fullStr Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
title_full_unstemmed Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
title_short Development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
title_sort development of a lupus nephritis suboptimal response prediction tool using renal histopathological and clinical laboratory variables at the time of diagnosis
url https://lupus.bmj.com/content/8/1/e000489.full
work_keys_str_mv AT jimcoates developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT bethanywolf developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT lindsaynhelget developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT davidjdillon developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT laurapparks developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT sallyeself developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT evelyntbruner developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis
AT evaneoates developmentofalupusnephritissuboptimalresponsepredictiontoolusingrenalhistopathologicalandclinicallaboratoryvariablesatthetimeofdiagnosis